Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2025-12-26 @ 12:49 PM
Study NCT ID:
NCT01349361
Status:
UNKNOWN
Last Update Posted:
2011-05-06
First Post:
2011-05-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D002280', 'term': 'Carcinoma, Basal Cell'}], 'ancestors': [{'id': 'D002277', 'term': 'Carcinoma'}, {'id': 'D009375', 'term': 'Neoplasms, Glandular and Epithelial'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D018295', 'term': 'Neoplasms, Basal Cell'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL'}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2011-03'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2011-03', 'lastUpdateSubmitDate': '2011-05-05', 'studyFirstSubmitDate': '2011-05-05', 'studyFirstSubmitQcDate': '2011-05-05', 'lastUpdatePostDateStruct': {'date': '2011-05-06', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2011-05-06', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2013-01'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'complete disappearance of the BCC'}]}, 'conditionsModule': {'conditions': ['Photodynamic Therapy', 'Basal Cell Carcinomas']}, 'descriptionModule': {'briefSummary': 'Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'eligibilityCriteria': 'Inclusion Criteria:\n\n* superficial BCC\n\nExclusion Criteria:\n\n* Immunosuppression'}, 'identificationModule': {'nctId': 'NCT01349361', 'briefTitle': 'Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight', 'organization': {'class': 'OTHER', 'fullName': 'Bispebjerg Hospital'}, 'officialTitle': 'Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight', 'orgStudyIdInfo': {'id': '2010-024517-31'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Daylight-PDT', 'interventionNames': ['Procedure: Daylight mediated photodynamic therapy']}], 'interventions': [{'name': 'Daylight mediated photodynamic therapy', 'type': 'PROCEDURE', 'armGroupLabels': ['Daylight-PDT']}]}, 'contactsLocationsModule': {'locations': [{'zip': '2400', 'city': 'Copenhagen NV', 'status': 'RECRUITING', 'country': 'Denmark', 'contacts': [{'name': 'Stine R Wiegell, MD, PhD', 'role': 'CONTACT', 'email': 'swie0001@bbh.regionh.dk'}, {'name': 'Stine R Wiegell, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Bispebjerg Hospital'}], 'centralContacts': [{'name': 'Stine R Wiegell, MD, PhD', 'role': 'CONTACT', 'email': 'swie0001@bbh.regionh.dk'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Bispebjerg Hospital', 'class': 'OTHER'}, 'responsibleParty': {'oldNameTitle': 'Hans Christian Wulf', 'oldOrganization': 'Bispebjerg Hospital'}}}}